Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway

Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway

Yue Zhou,1 Ai-Qing Nie,1 Shang Chen,2 Meng-Meng Wang,1 Rui Yin,1 Bo-Hao Tang,1 Yue-E Wu,1 Fan Yang,1 Bin Du,1 Hai-Yan Shi,3 Xin-Mei Yang,3 Guo-Xiang Hao,1 Xiu-Li Guo,4 Qiu-Ju Han,5 Yi Zheng,1,* Wei Zhao1,3,* 1Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education)...

Full description

Bibliographic Details
Main Authors:	Zhou Y, Nie AQ, Chen S, Wang MM, Yin R, Tang BH, Wu YE, Yang F, Du B, Shi HY, Yang XM, Hao GX, Guo XL, Han QJ, Zheng Y, Zhao W
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	Journal of Inflammation Research
Subjects:	disease-induced pharmacokinetic change renal transporters inflammatory cytokines clearance
Online Access:	https://www.dovepress.com/downregulation-of-renal-mrps-transporters-in-acute-lymphoblastic-leuke-peer-reviewed-fulltext-article-JIR

Similar Items

PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE
by: V. G. Belolipetskaya, et al.
Published: (2015-12-01)

Carboplatin Dosing for Adult Japanese Patients
by: HASEGAWA, YOSHINORI, et al.
Published: (2014)

A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials
by: Badrigilan S, et al.
Published: (2020-09-01)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
by: Bin Du, et al.
Published: (2021-03-01)

Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2
by: Lee WS, et al.
Published: (2018-03-01)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
by: Jesmin Permala Lohy Das, et al.
Published: (2018-03-01)

Analysis of the concordance between the estimated values of creatinine clearance using the Cockcroft-Gault equation and the real value determined in patients from the Hospital Clínica Bíblica
by: Jose Miguel Chaverri-Fernández, et al.
Published: (2016-01-01)

Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers
by: Kim Dao, et al.
Published: (2020-02-01)

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
by: Cristina Bagacean, et al.
Published: (2019-01-01)

Role of favipiravir in the treatment of COVID-19
by: Shashank Joshi, et al.
Published: (2021-01-01)

Blood concentrations of small extracellular vesicles are determined by a balance between abundant secretion and rapid clearance
by: Akihiro Matsumoto, et al.
Published: (2020-01-01)

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model
by: M G Vossen, et al.
Published: (2021-06-01)

Interspecies Scaling of Antibody–Drug Conjugates (ADC) for the Prediction of Human Clearance
by: Iftekhar Mahmood
Published: (2021-01-01)

Augmented Renal Clearance and How to Augment Antibiotic Dosing
by: Iris H. Chen, et al.
Published: (2020-07-01)

Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study
by: Wu CC, et al.
Published: (2019-08-01)

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
by: Nikola Kotur, et al.
Published: (2020-04-01)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
by: Škorić Biljana, et al.
Published: (2020-01-01)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
by: Xuan Gao, et al.
Published: (2021-07-01)

Comparative pharmacokinetic and renal clearance study of ceftiofur in cross breed Friesian and Buffalo calves
by: A. A. M. El-Gendy, et al.
Published: (2007-06-01)

Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M.
by: Viljoen, Michelle
Published: (2012)

Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M.
by: Viljoen, Michelle
Published: (2012)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
by: Mohd H. Abdul-Aziz, et al.
Published: (2017-11-01)

Enantioselective Pharmacokinetics of α-Lipoic Acid in Rats
by: Ryota Uchida, et al.
Published: (2015-09-01)

Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome
by: Pavel Gershokovich, et al.
Published: (2015-08-01)

LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner
by: Zheng Y, et al.
Published: (2021-08-01)

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
by: Darshana Jani, et al.
Published: (2018-02-01)

Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations
by: Muhammad F. Rasool, et al.
Published: (2019-11-01)

Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia
by: Zhang L, et al.
Published: (2021-04-01)

Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling Time
by: Sarah Baklouti, et al.
Published: (2021-04-01)

A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment
by: Lian Tang, et al.
Published: (2021-06-01)

Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity1
by: André P. van Beek, et al.
Published: (1998-02-01)

Panax notoginseng saponins increases the blood concentration of nifedipine by inhibiting CYP3A4 enzyme through PXR- and CAR-Mediated pathway
by: Qiu-Hong Li, et al.
Published: (2021-01-01)

Modifications of hemoglobin and myoglobin by Maillard reaction products (MRPs).
by: Aristos Ioannou, et al.
Published: (2017-01-01)

CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia
by: Woori Jang, et al.
Published: (2019-01-01)

Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients
by: Prashant R. Tembhare, et al.
Published: (2020-04-01)

MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia
by: Dou L, et al.
Published: (2013-08-01)

Investigation into the anti-inflammatory activity of PXR and the minor isoform PXR3
by: Alleyne, Jerusalem
Published: (2013)

Development of small extracellular vesicle-based therapeutics based on the elucidation and regulation of pharmacokinetic properties
by: Matsumoto, Akihiro
Published: (2020)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
by: Asín-Prieto, E., et al.
Published: (2022)

Chemotherapy in Childhood Acute Lymphoblastic Leukemia : In vitro cellular drug resistance and pharmacokinetics
by: Frost, Britt-Marie
Published: (2002)